LKFT compared with XLO: revenue, margins and what each company keeps, and the suppliers and customers both name

LKFTLakefront Biotherapeutics NV

Mkt capRevenueRevenue

XLOXilio Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

LKFTLakefront Biotherapeutics NV

XLOXilio Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LKFT

No earnings history for LKFT.

XLO1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−1.42%—

= impliedLKFT realized, solidXLO realized, hatchedOne scale, both sides: full bar = 2%× = |realized| ÷ impliedSource: market data

LKFTLakefront Biotherapeutics NV

32.14▲+0.38%

Mkt cap$2.1BRevenue—Revenue—

XLOXilio Therapeutics, Inc.

8.52▲+6.61%

Regular sessionNov 3 '26

Mkt cap$155.0MRevenue$19MQ2 FY26Revenue$44MFY25

Compare

Regular sessionNov 3 '26

LKFTLakefront Biotherapeutics NV

XLOXilio Therapeutics, Inc.

32.14▲+0.38%

Price

8.52▲+6.61%

$2.1B

Mkt cap

$155.0M

—

Revenue

$19MQ2 FY26

—

Revenue

$44MFY25

LKFT32.14▲+0.38%vsXLO8.52▲+6.61%Regular sessionNov 3 '26